2026-04-14T08:34:34Zhttps://recercat.cat/oai/requestoai:recercat.cat:2445/1649992025-12-05T04:24:18Zcom_2072_1057col_2072_478809col_2072_478917
Cost-effectiveness of insulin degludec versus insulin glargine U100 in patients with type 1 and type 2 diabetes in Portugal: evidence from SWITCH 1&2 trials
Darbà, Josep
Ascanio, Meritxell
Carvalho, Davide
Conde, Vasco
Pedersen, Kasper S.
Anàlisi cost-benefici
Salut pública
Diabetis
Insulina
Portugal
Cost effectiveness
Public health
Diabetes
Insulin
Portugal
Objectives: To assess the cost-effectiveness of insulin degludec (degludec) versus insulin glargine (glargine) U100 from a Portuguese healthcare perspective using data from SWITCH 1 & 2 trials. - - - Methods: A short-term model estimated cost-effectiveness of degludec versus glargine U100 in type 1 diabetes (T1DM) basal bolus (B/B) and type 2 diabetes (T2DM) basal oral therapy (BOT) patients. The model captured hypoglycaemia rates and insulin dosing. Clinical outcomes were obtained from SWITCH 1 & 2. Disutilities related to hypoglycaemic events and insulin, needles and blood glucose tests costs were also included. Benefits were measured in QALYs. One-way and probabilistic sensitivity analyses were conducted (...)
2020-06-10T08:05:43Z
2020-12-20T06:10:18Z
2019-12-20
2020-06-10T08:05:43Z
info:eu-repo/semantics/article
info:eu-repo/semantics/acceptedVersion
Versió postprint del document publicat a: http://www.revportdiabetes.com/rpd-dez-2019/
Revista Portuguesa de Diabetes, 2019, vol. 14, num. 4, p. 141-150
cc-by-nc-nd (c) Cortex - Publicacoes Tecnicas e Cientificas, 2019
http://creativecommons.org/licenses/by-nc-nd/3.0/es
info:eu-repo/semantics/openAccess
Cortex - Publicacoes Tecnicas e Cientificas
Articles publicats en revistes (Economia)